Abstract
Objective
Predictions of the future bone mineral density and bone loss rate are important to tailor medicine for women with osteoporosis, because of the possible presence of personal risk factors affecting the severity of osteoporosis in the future. We investigated whether it was possible to predict bone mineral density and bone loss rate in the future using artificial neural networks.
Results
A total of 135 women over 50 years old residing in T town of Wakayama Prefecture, Japan were analyzed to establish a statistical model. Artificial neural networks models were constructed using the two variables of bone mineral density and bone loss rate. The multiple correlation coefficients between the actual and measured values for lumbar and femoral bone mineral densities in 2003 showed R2 = 0.929 and R2 = 0.880, respectively, by linear regression analyses, while the values for bone loss rates in lumbar and femoral bone mineral densities were R2 = 0.694 and R2 = 0.609, respectively. Statistical models by artificial neural networks were superior to those by multiple regression analyses. The prediction of future bone mineral density values estimated by artificial neural networks was considered to be useful as a tool to tailor medicine for the early diagnosis of and intervention for women osteoporosis with women.
Electronic supplementary material
The online version of this article (10.1186/s13104-017-2910-4) contains supplementary material, which is available to authorized users.
Introduction
Fragility fractures of bones are one of the major problems in the field of postmenopausal osteoporosis. Especially, fractures of the proximal femur (femoral) often have a markedly negative impact on the quality of life of affected patients [1]. In addition, medical care for these patients is expensive [2]. Thus, the early diagnosis and prevention of osteoporosis are important medical issues in an advanced aging society. The diagnosis of osteoporosis is based on the presence of fragile bone fractures or low bone mineral densities (BMD), which are usually measured by dual energy X-ray absorptiometry (DXA). For the latter, values of no more than 70% YAM (young adult mean values), the same as a T-score (the bone density compared with what is normally expected in a healthy young adult of your sex in terms of standard deviations) ≤ − 2.5, were designated as cut-off values for the diagnosis of osteoporosis [3].
Artificial neural networks (ANN) are artificial adaptive systems that simulate certain characteristics of the human brain [4]. They are particularly suited for solving nonlinear problems. The ability to learn in an adaptive way makes ANN models powerful tools for data analysis. ANN has been shown to improve the predictive value of statistics in many areas of medicine [5]. In the field of bone metabolism, several studies reported about the efficacy of ANN. It was reported that the performance of ANN models for the prediction of BMD values using several parameters among postmenopausal women was superior to the conventional regression methods [6]. Also, ANN showed a better performance for predicting morphometric vertebral fractures in postmenopausal osteoporosis than logistic regression analysis [7]. However, no study has investigated the ability of ANN to predict future BMD and bone loss rate (BLR) values among postmenopausal women.
Thus, the aim of the present study was to investigate whether ANN models are able to predict future BMD and BLR values from person to person at lumbar and femoral sites of postmenopausal women, respectively, in the future. This is expected to be useful in combination with the use of FRAX (fracture risk assessment tool), an additional tool for the future prediction of bone fractures [8].
Main text
We constructed the statistical model of ANN using the information on female participants in Taiji study, T town, Wakayama, Japan. The study was designed as a population-based cohort, and it has been profiled in detail elsewhere [8, 9]. We have reported several studies on osteoporosis based on the data of Taiji study concerning BMD [8], risk factors affecting BMD [9] and determinants of bone loss [10].
In the present study, we used the information of 135 female participants with age ≥ 50 years at the baseline. Profiles of the subjects in the present study were shown in Additional file 1: Table S1. Input variables consisted of eleven variables: age, weight, height, age at menopause, age at menarche, durations after menopause, body mass index (BMI), percent of body fat, fat mass, lean body mass, and lumbar (L2–L4) or femoral BMD values which were measured in 1993, respectively. BMD was measured by DXA (HologicQDR-1000). Percent fat mass values were obtained using a reported formula [11]: body fat percent = 1.20 × BMI + 0.23 × age (years old) − 5.4. Then, the fat and lean body masses were calculated using body weight values. Output variables consisted of two variables: BMD at lumbar site (L2–L4) (LBMD) or BMD at proximal femur site (FBMD) values measured in 2003 and the BLR, respectively, calculated by the difference in BMD values from 1993 to 2003 divided by 10 (Additional file 2: Figure S1a, b). To increase the efficiency of ANN, we used values normalized by the transformations as follows except BMD and BLR values. First, we calculated (the difference between the measured and minimum values) divided by (the difference between the maximal and minimum values) for each input parameter. These maximal and minimal values were taken from the distribution of values from the entire study content. We obtained final values by taking each calculated value previously obtained and multiplying it by 0.8 (0.9–0.1) and then adding 0.1 to normalize the values from 0.1 to 0.9.
To predict BMD and BLR in 10 years at lumbar and femoral sites of postmenopausal women, ANN models were built. In detail, multilayer perceptrons were used with 11 neurons in the input layer, four neurons in one hidden layer, and two neurons in the output layer. After performing a number of trials (around 50–100 times), the most appropriate model was selected based on the better R2 value by the single and fivefold cross-validation methods. In addition, we also obtained predicted values for these parameters by multiple regression analyses (MRA).
To evaluate the predicted BMD and BLR values at lumbar and femoral sites, we used linear regression analyses. The statistical comparison of each statistical model was performed using Akaike’s information criterion (AIC), Schwartz’s Bayesian information criterion (BIC), and multiple correlation coefficients (R2) values corrected by degrees of freedom (R2 values), respectively. For the diagnosis of osteoporosis, we estimated the sensitivity, specificity, and c-index by receiver operating characteristic (ROC) analyses to evaluate the methods of ANN and MRA. Data are shown as a mean with 95% confidential interval (CI) values. We used JMP 8.0 (SAS, Japan) for the analyses of ANN. For the other statistical analyses, we used JMP9.0 or Dr. SPSS II (SPSS), respectively. A P value of < 0.05 was considered significant.
The R2 values between the actual and predicted values of LBMD and FBMD in 2003 were revealed to be R2 = 0.929 and R2 = 0.880, respectively, by linear regression analyses (Fig. 1), while the values for BLR of LBMD (LBLR) and FBMD (FBLR) were 0.694 and 0.609, respectively (Fig. 2). The sensitivity, specificity, and c-index for the predicted diagnosis of osteoporosis for the LBMD and FBMD in 10 years using this model were 80.0, 90.5%, and 0.825 and 80.6, 93.3%, and 0.870, respectively (Table 1).
Table 1.
AIC | BIC | R2 | Sensitivity (%) | Specificity (%) | c-index | |
---|---|---|---|---|---|---|
Lumbar BMD | ||||||
ANN | 551 | 558 | 0.929 | 80.0 | 90.5 | 0.825 |
MRA | 636 | 643 | 0.803 | 83.3 | 87.3 | 0.853 |
Femoral BMD | ||||||
ANN | 538 | 545 | 0.880 | 80.6 | 93.3 | 0.870 |
MRA | 625 | 632 | 0.687 | 61.3 | 93.3 | 0.773 |
Lumbar BLR | ||||||
ANN | 131 | 139 | 0.694 | |||
MRA | 228 | 325 | 0.137 | |||
Femoral BLR | ||||||
ANN | 135 | 143 | 0.609 | |||
MRA | 206 | 213 | 0.153 |
We also compared the statistical models obtained by ANN with those by MRA for LBMD and FBMD values, respectively. For both sites of bone, AIC and BIC values for BMD by ANN were much lower than by MRA (Table 1), suggesting that the statistical models obtained by ANN were superior to those by MRA. Also, R2 values obtained by ANN for lumbar and femoral sites (0.929 and 0.880, respectively) were much higher than those by MRA (0.803 and 0.687, respectively). In addition, R2 values obtained by ANN for LBLR and FBLR (0.694 and 0.609, respectively) were much higher than those by MRA (0.137 and 0.153, respectively). These data re-confirmed that the statistical method of ANN was superior to that of MRA (Table 1). Moreover, we further compared the statistical models by ANN for LBLR and FBLR with those for LBMD and FBMD, respectively (Table 1). The R2 values for LBLR and FBLR were 0.694 and 0.609, respectively, being much lower than those for LBMD (0.929) and FBMD (0.880), suggesting that the statistical models for BLR were inferior to those for BMD (Table 1).
We showed that we could predict future BMD and BLR in 10 years on person-to -person basis using conventional parameters. These parameters were the age, weight, height, age at menopause, age at menarche, durations after menopause, BMI, percent of body fat, fat mass, lean body mass, and lumbar (L2–L4) or femoral BMD values. Because they were easy to obtain on the first visit to osteoporosis clinics, the use of these findings may further reduce future bone fractures of post-menopausal women.
Reducing the bone fracture rate of women is one of the goals of therapy for osteoporosis. Since the bone mineral density is responsible for 70% of the bone strength and because the occurrence of bone fractures is thought to be associated with the bone strength [12], the discovery of a new tool in this study to predict future BMD values may be useful to reduce the bone fracture rate in post-osteoporosis women. In addition, bone fractures of the proximal femur often impair the quality of life of affected patients, with increases in medical care and costs. Thus, the early diagnosis and prevention of osteoporosis are important medical issues in an advanced aging society. Because of the possible presence of different personal risks for the severity of osteoporosis in the future, our findings showing the ability to predict individual BMD in 10 years are thought to be useful as a tool of tailored medicine, which might contribute to some extent to the prevention of and decisions regarding early therapy for post-menopausal osteoporosis.
FRAX is the only tool to predict future bone fracture in 10 years. FRAX is thought to be a tool reflecting all fractures derived from secondary osteoporosis, such as rheumatoid arthritis, steroid osteoporosis, type I diabetes mellitus, and hyperthyroidism [13]. On the other hand, our data were based on the only data for women with post-menopausal osteoporosis. Thus, the combined use of FRAX and the detailed analysis by using ANN models may lead to increased power for the future prediction of bone fractures due to post-menopausal osteoporosis.
ANN are artificial adaptive systems that emulate certain characteristics of the human brain [1]. The advantages of ANN include their ability to extract hidden features from input information and their robustness against assumptions concerning the type of distribution of input data and against the influence of diagnostic noise. In many reports, ANN have been used to predict the present BMD based on risk factors for osteoporosis. Certain factors such as the age, a low body weight, and years since menopause have been suggested by most studies to be associated with a low bone mass [14, 15]. However, the prediction of a future BMD using ANN has not been reported. In this study, R2 values between the actual and predicted values for of LBMD and FBMD were 0.929 and 0.880, respectively, based on linear regression analyses. In addition, the sensitivity, specificity, and c-index for the predicted diagnosis of osteoporosis of the LBMD in 10 years using this model were 80.0, 90.5%, and 0.825 while the same values for FBMD were 80.6, 93.3%, and 0.870, respectively. We suggest that our method is applicable for clinical use for the prevention of and decisions regarding early therapy for postmenopausal osteoporosis. To our knowledge, this is the first study to show the usefulness of ANN for the prediction of BMD at lumbar and femoral sites in the future.
We also showed in our study that ANN were superior to MRA for predicting future LBLR and FBLR values, respectively. These data are expected because it is very well known that the prediction capability of ANN is superior to MRA. However, this is the first investigation suggesting that ANN are clearly superior to MRA for predicting LBLR and FBLR in future. We speculated that the superiority of ANN might be derived from the fact that some of the biological findings might be non-linear in nature, although the actual reasons remain unknown.
It is concluded that the application of ANN to predict future BMD in advance of the first visit of a patient to an osteoporosis clinic may lead to early intervention to avoid possible fragile bone fractures due to severe post-menopausal osteoporosis.
Limitations
Firstly, it is possible that the prediction in our study is only applicable to the BMD of women with osteoporosis living in regions similar to T town, Wakayama, Japan. This is because of the nature of ANN, which processed the data so precisely that the results might only reflect the characteristics of the region where the study was conducted. Since T town is a rural region of Japan, it is possible that our data are not applicable to women with osteoporosis living in big cities with large populations in Japan.
Secondly, the presence of some problems due to the small sample size and the lack of the important input variables such as the daily physical activities, which are thought to have deep impacts on BMD and BLR values via the applied force to bone, need to be investigated by a large cohort from different countries in future.
Additional files
Authors’ contributions
The manuscript was drafted by MS and revised with assistance of TY, TI, TT, KA and NY. TI and KA contributed to the data collecting and screening the data prior to the ordinary statistical analyses. TY modified the previous study design and performed statistical analyses (artificial neural networks). NY designated the original study design and also conducted an extended work for the previous study. Also, NY gave useful suggestions for modifying the original designs by TY. All authors read and approved the final manuscript.
Acknowledgements
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
Consent to publish
Not applicable.
Ethical approval and consent to participate
This study was approved by the Ethical committee of Wakayama Prefectural Medical University. The ethical committee reference number was 183. Informed consents were obtained from the participants with written consents, which were written in the previous publication in Nihon Eiseigaku Zasshi. 1996; 51:677–84.
Funding
For the previous publication in JBMM 2002, Noriko Yoshimura obtained Grants-in-Aid for Scientific Research A07770288 from the Ministry of Education, Science, Sports, and Culture in Japan. Also, she was in receipt of a grant from the Japanese Society for the Promotion of Science.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abbreviations
- BMD
bone mineral density
- BLR
bone loss rate
- ANN
artificial neural networks
- LBMD
BMD at lumbar site (L2–L4)
- FBMD
BMD at proximal femur site (FBMD)
- DXA
dual energy X-ray absorptionmetry
- YAM
young adult mean values
- FRAX
fracture risk assessment tool
- MRA
multiple regression analysis
- CI
confidential interval
- R2
multiple correlation coefficients
- AIC
Akaike’s information criterion
- BIC
Schwartz’s Bayesian information criterion
- ROC
receiver operating characteristic
Footnotes
Electronic supplementary material
The online version of this article (10.1186/s13104-017-2910-4) contains supplementary material, which is available to authorized users.
Contributor Information
Mitsunori Shioji, Email: m-shio@cf6.so-net.ne.jp.
Takehisa Yamamoto, Phone: + 81-727-28-2001, Email: t.yamamoto@minoh-hp.jp.
Takeshi Ibata, Email: t.ibata@minoh-hp.jp.
Takayuki Tsuda, Email: tsuda-takayuki@kansaih.iohas.go.jp.
Kazushige Adachi, Email: k.adachi@minoh-hp.jp.
Noriko Yoshimura, Email: noripu1126epi@icloud.com.
References
- 1.Suzuki H, Yoshida H. Low bone mineral density at femoral neck is a predictor of increased mortality in elderly Japanese women. Osteoporos Int. 2010;21:71–79. doi: 10.1007/s00198-009-0970-6. [DOI] [PubMed] [Google Scholar]
- 2.Motohashi T, Hamada H, Lee J, Sekimoto M, Imanaka Y. Factors associated with prolonged length of hospital stay of elderly patients in acute care hospitals in Japan: a multilevel analysis of patients with femoral neck fracture. Health Policy. 2013;111:60–67. doi: 10.1016/j.healthpol.2013.03.014. [DOI] [PubMed] [Google Scholar]
- 3.Soen S, Fukunaga M, Sugimoto T, Sone T, Fujiwara S, Endo N, et al. Japanese society for bone and mineral research and Japan osteoporosis society joint review committee for the revision of the diagnostic criteria for primary osteoporosis. J Bone Miner Metab. 2013;31:247–257. doi: 10.1007/s00774-013-0447-8. [DOI] [PubMed] [Google Scholar]
- 4.Cross SS, Harrison RF, Kennedy RL. Introduction to neural networks. Lancet. 1995;346:1075–1079. doi: 10.1016/S0140-6736(95)91746-2. [DOI] [PubMed] [Google Scholar]
- 5.Lisboa PJG. A review of evidence of health benefit from artificial neural networks in medical intervention. Neural Netw. 2002;15:11–39. doi: 10.1016/S0893-6080(01)00111-3. [DOI] [PubMed] [Google Scholar]
- 6.Sadatsafavi M, Moayyeri A, Soltani A, Larijani B, Nouraie M, Akhondzadeh S. Artificial neural networks in prediction of bone density among post-menopausal women. J Endocrinol Invest. 2005;28:425–431. doi: 10.1007/BF03347223. [DOI] [PubMed] [Google Scholar]
- 7.Eller-Vainicher C, Chiodini I, Santi I, Massarotti M, Pietrogrande L, Cairoli E, et al. Recognition of morphometric vertebral fractures by artificial neural networks: analysis from GISMO Lombardia database. PLoS ONE. 2011;6:e27277. doi: 10.1371/journal.pone.0027277. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Kasamatsu T, Yoshimura N, Morioka S, Sugita K, Hashimoto T. A population survey on bone mineral density in a fishing village in Wakayama prefecture (part 1); distribution of bone mineral density by sex and age based on a representative sample of the community. Nippon Eiseigaku Zasshi. 1996;50:1084–1092. doi: 10.1265/jjh.50.1084. [DOI] [PubMed] [Google Scholar]
- 9.Yoshimura N, Kasamatsu T, Morioka S, Hashimoto T. A population survey on bone mineral density in a fishing village in Wakayama Prefecture (part 2); the analysis of the risk factors affecting the bone mineral density. Nippon Eiseigaku Zasshi. 1996;51:677–684. doi: 10.1265/jjh.51.677. [DOI] [PubMed] [Google Scholar]
- 10.Yoshimura N, Hashimoto T, Morioka S, Sakata K, Kasamatsu T, Cooper C. Determinants of bone loss in a rural Japanese community: the Taiji study. Osteoporos Int. 1998;8:604–610. doi: 10.1007/s001980050106. [DOI] [PubMed] [Google Scholar]
- 11.Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr. 1991;65(2):105–114. doi: 10.1079/BJN19910073. [DOI] [PubMed] [Google Scholar]
- 12.Kanis JA. Treatment of osteoporotic fracture. Lancet. 1984;1:27–33. doi: 10.1016/S0140-6736(84)90191-0. [DOI] [PubMed] [Google Scholar]
- 13.Kains JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19(4):385–397. doi: 10.1007/s00198-007-0543-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Ribot C, Pouilles JM, Bonneu M, Tremollieres F. Assessment of the risk of post-menopausal osteoporosis using clinical factors. Clin Endocrinol (Oxf) 1992;36:225–228. doi: 10.1111/j.1365-2265.1992.tb01436.x. [DOI] [PubMed] [Google Scholar]
- 15.Bauer DC, Browner WS, Cauley JA, Orwoll ES, Scott JC, Black DM, The Study of Osteoporotic Fractures Research Group et al. Factors associated with appendicular bone mass in older women. Ann Intern Med. 1993;118:657–665. doi: 10.7326/0003-4819-118-9-199305010-00001. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.